Matches in Nanopublications for { ?s ?p "[The distinct and favorable expression profile of C35 spanning early through late stages of disease, including high frequency of overexpression in various breast carcinoma, abundant expression in distant metastases, and either absence or low level expression in normal human tissues, warrants further investigation of the relevance of C35 as a biomarker and/or a target for development of broadly applicable cancer-specific therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP718028.RAi-bj1qRv2WFlneEelVYJuNN7I46snIBfTpnEqJD10gY130_assertion description "[The distinct and favorable expression profile of C35 spanning early through late stages of disease, including high frequency of overexpression in various breast carcinoma, abundant expression in distant metastases, and either absence or low level expression in normal human tissues, warrants further investigation of the relevance of C35 as a biomarker and/or a target for development of broadly applicable cancer-specific therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718028.RAi-bj1qRv2WFlneEelVYJuNN7I46snIBfTpnEqJD10gY130_provenance.
- NP867881.RAVJ1UIWo8gmEzh48hoT8JL4y24rB8tLJKEUYkBQov4EA130_assertion description "[The distinct and favorable expression profile of C35 spanning early through late stages of disease, including high frequency of overexpression in various breast carcinoma, abundant expression in distant metastases, and either absence or low level expression in normal human tissues, warrants further investigation of the relevance of C35 as a biomarker and/or a target for development of broadly applicable cancer-specific therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867881.RAVJ1UIWo8gmEzh48hoT8JL4y24rB8tLJKEUYkBQov4EA130_provenance.
- NP424332.RA4EAGEXPey57G_6I72xbXh3kb-NnOmnvWRFB00N-t6X4130_assertion description "[The distinct and favorable expression profile of C35 spanning early through late stages of disease, including high frequency of overexpression in various breast carcinoma, abundant expression in distant metastases, and either absence or low level expression in normal human tissues, warrants further investigation of the relevance of C35 as a biomarker and/or a target for development of broadly applicable cancer-specific therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424332.RA4EAGEXPey57G_6I72xbXh3kb-NnOmnvWRFB00N-t6X4130_provenance.
- NP827608.RA78WVOviEIUShFxyMum1eu1MN7DE1YagsOEcNxanNe_8130_assertion description "[The distinct and favorable expression profile of C35 spanning early through late stages of disease, including high frequency of overexpression in various breast carcinoma, abundant expression in distant metastases, and either absence or low level expression in normal human tissues, warrants further investigation of the relevance of C35 as a biomarker and/or a target for development of broadly applicable cancer-specific therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827608.RA78WVOviEIUShFxyMum1eu1MN7DE1YagsOEcNxanNe_8130_provenance.